AstraZeneca Pharma shares gain 3% on CDSCO approval for sale of Tremelimumab
- Hot Stocks
admin
- 0
- 1 minute read
The receipt of this permission paves way for the launch of Tremelimumab solution of 20 mg/ml in India. Tremelimumab, in combination with Durvalumab (Imfinzi), is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC).
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1116617012-6a8112931e6f4375b6e1481b39eeeae8.jpg "How to Become a Real Estate Agent: A Step-by-Step Guide")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1255077848-13fe034d27ba4d1398930d76d7be6693.jpg "6 Best Paying Jobs in Finance")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1246195248-4209faa3f1854e648d38836ebd402e96.jpg "Forex Market Sentiment Indicators and How To Use Them")